Melphalan Hydrochloride Patent Expiration
Melphalan Hydrochloride was first introduced by Apotex Inc
Melphalan Hydrochloride Patents
Given below is the list of patents protecting Melphalan Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Ivra | US10537520 | Stable liquid formulations of melphalan | Jun 29, 2036 | Apotex |
Hepzato | US9707331 | Apparatus for removing chemotherapy compounds from blood | Sep 17, 2034 | Delcath Systems Inc |
Hepzato | US9314561 | Filter and frame apparatus and method of use | Feb 07, 2034 | Delcath Systems Inc |
Evomela | US10040872 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Jan 30, 2034 | Acrotech Biopharma |
Evomela | US9493582 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Feb 27, 2033 | Acrotech Biopharma |
Hepzato | US10195334 | Filter and frame apparatus and method of use | Jan 16, 2033 | Delcath Systems Inc |
Hepzato | US11083831 | Filter and frame apparatus and method of use | Dec 30, 2032 | Delcath Systems Inc |
Hepzato | US11833286 | Filter and frame apparatus and method of use | Dec 30, 2032 | Delcath Systems Inc |
Hepzato | US10098997 | Apparatus for removing chemotherapy compounds from blood | Nov 07, 2032 | Delcath Systems Inc |
Hepzato | US10369264 | Apparatus for removing chemotherapy compounds from blood | Nov 07, 2032 | Delcath Systems Inc |
Hepzato | US10569004 | Apparatus for removing chemotherapy compounds from blood | Nov 07, 2032 | Delcath Systems Inc |
Hepzato | US11241522 | Apparatus for removing chemotherapy compounds from blood | Nov 07, 2032 | Delcath Systems Inc |
Hepzato | US11633528 | Apparatus for removing chemotherapy compounds from blood | Nov 07, 2032 | Delcath Systems Inc |
Evomela | US10940128 | Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same | Jun 14, 2030 | Acrotech Biopharma |
Evomela | US10864183 | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same | May 28, 2030 | Acrotech Biopharma |
Evomela | US11020363 | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same | May 28, 2030 | Acrotech Biopharma |
Evomela | US8410077 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Acrotech Biopharma |
Evomela | US9200088 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Acrotech Biopharma |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Melphalan Hydrochloride's patents.
Latest Legal Activities on Melphalan Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Melphalan Hydrochloride.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Jan, 2023 | US10537520 |
Post Issue Communication - Certificate of Correction | 31 Jan, 2020 | US10537520 |
Recordation of Patent Grant Mailed Critical | 21 Jan, 2020 | US10537520 |
Patent Issue Date Used in PTA Calculation Critical | 21 Jan, 2020 | US10537520 |
Issue Notification Mailed Critical | 01 Jan, 2020 | US10537520 |
Dispatch to FDC | 16 Dec, 2019 | US10537520 |
Application Is Considered Ready for Issue Critical | 16 Dec, 2019 | US10537520 |
Issue Fee Payment Received Critical | 03 Dec, 2019 | US10537520 |
Issue Fee Payment Verified Critical | 03 Dec, 2019 | US10537520 |
Printer Rush- No mailing | 02 Dec, 2019 | US10537520 |
Melphalan Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Melphalan Hydrochloride Generics
Several generic applications have been filed for Melphalan Hydrochloride. The first generic version for Melphalan Hydrochloride was by Mylan Institutional Llc and was approved on Jun 9, 2009. And the latest generic version is by Hetero Labs Ltd and was approved on May 23, 2024.
Given below is the list of companies who have filed for Melphalan Hydrochloride generic.
1. ACTAVIS LLC
Actavis Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Mar 6, 2020 |
2. ALMAJECT
Almaject Inc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Almaject.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | May 17, 2019 |
3. ARTHUR GRP
Arthur Group Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Arthur Grp.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Sep 13, 2019 |
4. BPI LABS
Bpi Labs Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Bpi Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | May 8, 2020 |
5. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Dec 8, 2017 |
6. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Aug 22, 2016 |
7. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Dec 22, 2017 |
8. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | May 28, 2019 |
9. HETERO LABS
Hetero Labs Ltd has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | May 23, 2024 |
10. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Oct 28, 2010 |
11. INGENUS PHARMS LLC
Ingenus Pharmaceuticals Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Ingenus Pharms Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Feb 18, 2020 |
12. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | May 28, 2021 |
13. MYLAN INSTITUTIONAL
Mylan Institutional Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Institutional.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Oct 27, 2009 |
14. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Feb 28, 2017 |
15. USWM
Uswm Llc has filed for 1 generic for Melphalan Hydrochloride. Given below are the details of the strengths of this generic introduced by Uswm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 50MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | May 3, 2019 |